CD274 and neoplasm: The PD-L1 combined positive score (CPS) is a clinically validated score generated by analysing the ratio of PD-L1 positive cells in comparison with all tumor cells and, as discussed below, is utilised as a as a predictive biomarker for ICI use in EGAC across a number of clinical trials [13].